These include traditional heart failure biomarkers (e.g., NT-pro-BNP, BNP, and hsTnT) as well as inflammation-related biomarkers (e.g., hsCRP and complement C3a) [6,9,14,15]. This evidence concerns the gene NPPB and heart failure.